FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Dr Reddys Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500124 P/E (TTM) :15.31
ISIN Demat:INE089A01031 Div & Yield %:0.63 EPS (TTM) :82.59
Book Value (RS) :345.7486895 Market Cap (Rs Cr.):105561.95 Face Value (RS) :1
    Change Company 
Particulars Quarter Ended
(Jun 2025)		 Quarter Ended
(Jun 2024)		 Quarter Ended
(% Var)
Sales 7,788.70 5,823.90 33.74
Other Income 398.30 217.80 82.87
PBIDT 4,235.30 2,170.80 95.10
Interest 19.20 7.10 170.42
PBDT 4,216.10 2,163.70 94.86
Depreciation 279.80 249.80 12.01
PBT 3,936.30 1,913.90 105.67
Tax 941.70 466.60 101.82
Deferred Tax 33.40 30.10 10.96
PAT 2,961.20 1,417.20 108.95

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)